US-China Deal's Patent Rules Will Boost Branded Drug Cos.
The preliminary trade agreement signed by the U.S. and China this week should aid the branded pharmaceutical industry by creating a system to resolve patent disputes over generic drugs before they...To view the full article, register now.
Already a subscriber? Click here to view full article